Infinity Pharmaceuticals

January 14, 2020

Market feeling frothy? You might be right

January 09, 2020

Verastem plays the Kras card

For $3m Verastem adds to its pipeline another asset that a bigger company had given up on.

August 30, 2018

Seeking alpha in PI3K inhibition

Novartis hails the most advanced alpha-directed PI3K inhibitor after success in breast cancer, but it’s not the only one.

December 14, 2017

Ash 2017 winners and losers – Déjà vu

November 02, 2017

Ash 2017 preview – Blueprint and Stemline celebrate

October 26, 2017

SITC preview – All eyes on Incyte and Infinity

September 08, 2017

Snippet Roundup: PI3Ks not dead, but PD(L)-1 multiple myeloma hopes falter

March 03, 2017

AACR – Rags to riches to rags again

March 03, 2017

AACR – Rags to riches to rags again

December 06, 2016

Ash – Early data for next generation of Imbruvica’s challengers

November 04, 2016

Snippet roundup: Infinity sells duvelisib, Celldex buys Kolltan and Zimmer Biomet has supply woes

Load More